Zenith Epigenetics Corp. is a research and development biotechnology company focused on new and innovative drugs by leveraging its proprietary epigenetics platform. The company's epigenetic drug discovery platform functions by inhibiting BET bromodomains, having the potential to impact multiple diseases including autoimmune and oncology.

Learn More

News Highlights

Zenith Epigenetics Closes $8 million Private Placement

CALGARY, March 14, 2014 - Zenith Epigenetics Corp. ("Zenith" or the "Company") today announced that it has closed a private placement of 8,000,000 common shares at a price of US$1.00 per share for gross proceeds of US$8,000,000 (the "Private Placement") to Eastern Capital Limited ("Eastern") and NGN BioMed Opportunity II, L.P. ("NGN"). Eastern and NGN subscribed for 6,000,000 and 2,000,000 common shares, respectively. The shares are subject to a four month hold period.

After giving effect to the Private Placement, Eastern and NGN hold 19,200,000 and 8,769,339 common shares, respectively, of Zenith, representing approximately 22.9% and 10.5%, respectively, of Zenith's issued and outstanding common shares. Eastern and NGN also hold 2,048,640 and 1,683,665 common share purchase warrants of Zenith, respectively.

Read More

Zenith Epigenetics Board Update & Webcast Announcement

Calgary, Alberta, February 11, 2014 - Zenith Epigenetics announced today that Arthur Higgins will be stepping down from the Board of Directors after fulfilling his commitment in helping Zenith Epigenetics to be established as a spin out company from Resverlogix Corp. Zenith Epigenetics' management and Board of Directors would like to thank Arthur for his commitment and positive input during this time.

In addition, Zenith Epigenetics Corp. will be hosting a conference call and webcast on Thursday, February 20, 2014 at 11 am MDT / 1 pm ET. The call will update the market on current developments and clinical progress.

Read More

Zenith Epigenetics Webcast

Zenith hosted a live corporate update conference call and webcast on Thursday, February 20, 2014. Please access the archived webcast here: http://services.choruscall.ca/links/zenith140220.html

Read More Add This to my Calendar

Sign Up For Updates

Please submit your name and email for latest news.

Email Address*